首页|鼻窦药物支架对慢性鼻窦炎伴鼻息肉患者术后炎症因子水平及鼻黏膜功能的影响

鼻窦药物支架对慢性鼻窦炎伴鼻息肉患者术后炎症因子水平及鼻黏膜功能的影响

扫码查看
目的 观察鼻窦药物支架对慢性鼻窦炎伴鼻息肉(CRSwNP)患者术后炎症因子水平及鼻黏膜功能的影响。方法 按不同治疗方法将2022年1月至2023年12月于周口市中心医院治疗的84例CRSwNP患者分为2组,各42例。2组均采用功能性内镜鼻窦手术(FESS)治疗,对照组FESS术后采用口服糖皮质激素治疗,观察组FESS术后采用置入鼻窦药物支架治疗。比较2组病情严重程度、自我症状、炎症严重程度、鼻黏膜功能、生活质量、炎症因子及不良反应。结果2组术后隆德-肯尼迪(Lund-Kennedy)评分、隆德-麦凯(Lund-Mackay)评分、视觉模拟评分(VAS)及γ-干扰素(IFN-γ)、白细胞介素-2(IL-2)、白细胞介素-6(IL-6)水平低于术前,纤毛清除速度高于术前,术后心理情绪评分、临床症状评分、日常生活活动评分低于术前,总体健康评分高于术前,差异有统计学意义(P<0。05);且观察组采用置入鼻窦药物支架治疗术后心理情绪评分为(3。49±1。02)分,低于对照组(4。13±1。50)分,总体健康评分为(9。55±1。74)分,高于对照组(8。52±2。02)分,不良反应总发生率(2。4%)低于对照组(19。0%),差异有统计学意义(t=2。287、2。504,P=0。025、0。014;x2=4。480,P=0。034);2 组术后 Lund-Kennedy 评分、Lund-Mackay 评分、VAS 及 IFN-γ、IL-2、IL-6 水平比较,差异无统计学意义(P>0。05)。结论FESS术后口服糖皮质激素与置入鼻窦药物支架治疗CRSwNP效果相当,均可控制患者病情,减轻炎症反应,改善鼻黏膜功能及临床症状,但置入鼻窦药物支架治疗不良反应少,可提高患者生活质量。
Effects of sinus medication stent on postoperative inflammatory cytokine levels and nasal mucosal function in patients with chronic sinusitis and nasal polyps
Objective To observe the effects of sinus medication stent on postoperative inflammatory cy-tokine levels and nasal mucosal function in patients with chronic sinusitis and nasal polyps(CRSwNP).Methods According to different treatment methods,a total of 84 CRSwNP patients treated in Zhoukou Central Hospital from January 2022 to December 2023 were divided into a control group and an observation group,with 42 cases in each group.Both groups were treated with functional endoscopic sinus surgery(FESS).The control group was treated with oral corticosteroids after FESS,while the observation group was treated with sinus medication stent after FESS.The severity of the condition,severity of symptoms,severity of inflammation,nasal mucosal function,quality of life,in-flammatory factors,and adverse reactions were compared between two groups.Results The postoperative Lund Kennedy score,Lund Mackay score,Visual Analog Scale(VAS)score,and levels of IFN-y,IL-2,and IL-6 in both groups were lower than before surgery;The cilia clearance rate was higher than before surgery;Postoperative psychological and emotional scores,clinical symptom scores,and daily living activity scores were all lower than preoperative scores;The overall health score was higher than before surgery,and the difference was statistically significant(P<0.05).After the use of sinus medication stent for treatment,the psychological and emo-tional scores of the observation group were lower than those of the control group[(3.49±1.02)points vs(4.13±1.50)points],and the overall health score of the observation group was higher than that of the control group[(9.55±1.74)points vs(8.52±2.02)points].The total incidence of adverse reactions in the observation group was lower than that of the control group[(2.4%)vs(19.0%)],and the above differences were statistically significant(t=2.287,2.504,P=0.025、0.014;x2=4.480,P=0.034).There was no statistically significant difference in postoperative Lund Kennedy score,Lund Mackay score,VAS score,and levels of IFN-γ,IL-2,and IL-6 between the two groups(P>0.05).Conclusion Oral corticosteroids and sinus drug stent implantation after FESS surgery are equally effective in CRSwNP,both of which can control the condition of patients,reduce inflammation,improve nasal mucosal function and clinical symptoms.However,sinus medication stent has fewer adverse reactions and can improve the life quality of patients.

SinusitisNasal polypsGlucocorticoidsNasal mucosaDrug-related side effects and adverse reactionsSinus medication stent

杜林芳

展开 >

周口市中心医院耳鼻咽喉科,河南周口 466000

鼻窦炎 鼻息肉 糖皮质激素类 鼻黏膜 药物相关副作用和不良反应 鼻窦药物支架

2024

中国药物与临床
中国医院协会

中国药物与临床

影响因子:0.846
ISSN:1671-2560
年,卷(期):2024.24(17)